Some conservatives say considering race when allocating COVID treatments discriminates against white people

Indonesia Berita Berita

Some conservatives say considering race when allocating COVID treatments discriminates against white people
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 chicagotribune
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 91%

Health officials have long said there is a strong case for considering race as one of many risk factors in COVID-19 treatments. And there is no evidence that race alone is being used to decide who gets medicine.

Some conservatives are taking aim at policies that allow doctors to consider race as a risk factor when allocating scarce COVID-19 treatments, saying the protocols discriminate against white people.

JP Leider, a senior fellow in the Division of Health Policy and Management at the University of Minnesota who helped develop that state’s allocation criteria, noted that prioritization has been going on for some time because there aren’t enough treatments to go around.“You have to pick who comes first,” Leider said. “The problem is we have extremely conclusive evidence that across the United States are having worse COVID outcomes compared to white folks. ...

Omicron has rendered two widely available antibody treatments ineffective, leaving only one, which is in short supply. St. Louis-based SSM Health, which serves patients in Illinois, Missouri, Oklahoma and Wisconsin, required patients to score 20 points on a risk calculator to qualify for COVID-19 antibody treatment. Non-whites automatically got seven points.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

chicagotribune /  🏆 8. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FDA acts to expand use of treatment for COVID-19 patients with mild-to-moderate diseaseFDA acts to expand use of treatment for COVID-19 patients with mild-to-moderate diseasePreviously, the use of Veklury, a Gilead Sciences Inc. drug, was limited to those requiring hospitalization.
Baca lebih lajut »

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severityEarly non-neutralizing, afucosylated antibody responses are associated with COVID-19 severityUnlike antibodies elicited by mRNA vaccines against COVID19, some non-neutralizing, afucosylated IgG antibodies specific to SARSCoV2 may be associated with progression to more severe disease, according to new research in ScienceTM.
Baca lebih lajut »

Fauci: Omicron COVID-19 infections likely to peak in FebruaryFauci: Omicron COVID-19 infections likely to peak in FebruaryDr. Anthony Fauci said he was 'as confident as you can be' that states will hit their highest point of infections in February
Baca lebih lajut »

COVID-19 live updates: New Zealand imposes restrictions amid omicron outbreakCOVID-19 live updates: New Zealand imposes restrictions amid omicron outbreakNew Zealand Prime Minister Jacinda Ardern revealed that her own wedding will be postponed as she announced a new set of COVID-19 restrictions amid the country’s first omicron outbreak.
Baca lebih lajut »

Southlake’s COVID-19 cases on the rise with 5,554 confirmed casesSouthlake’s COVID-19 cases on the rise with 5,554 confirmed casesSince the outbreak of the coronavirus, Southlake has recorded a total of 5,310 confirmed cases, an increase of 352 cases over the past week, according to...
Baca lebih lajut »



Render Time: 2025-04-04 22:45:50